AU2001260457A1 - Biological materials and methods for use in the prevention or treatment of infections - Google Patents

Biological materials and methods for use in the prevention or treatment of infections

Info

Publication number
AU2001260457A1
AU2001260457A1 AU2001260457A AU6045701A AU2001260457A1 AU 2001260457 A1 AU2001260457 A1 AU 2001260457A1 AU 2001260457 A AU2001260457 A AU 2001260457A AU 6045701 A AU6045701 A AU 6045701A AU 2001260457 A1 AU2001260457 A1 AU 2001260457A1
Authority
AU
Australia
Prior art keywords
infections
prevention
treatment
methods
biological materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260457A
Inventor
Gordon Dougan
Gad Meir Frankel
Stephen John Matthews
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Publication of AU2001260457A1 publication Critical patent/AU2001260457A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/06—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
AU2001260457A 2000-05-31 2001-05-29 Biological materials and methods for use in the prevention or treatment of infections Abandoned AU2001260457A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0013115 2000-05-31
GBGB0013115.1A GB0013115D0 (en) 2000-05-31 2000-05-31 Biological materials and methods for use in the prevention or treatment of infections
PCT/GB2001/002361 WO2001092534A1 (en) 2000-05-31 2001-05-29 Biological materials and methods for use in the prevention or treatment of infections

Publications (1)

Publication Number Publication Date
AU2001260457A1 true AU2001260457A1 (en) 2001-12-11

Family

ID=9892624

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260457A Abandoned AU2001260457A1 (en) 2000-05-31 2001-05-29 Biological materials and methods for use in the prevention or treatment of infections

Country Status (3)

Country Link
AU (1) AU2001260457A1 (en)
GB (2) GB0013115D0 (en)
WO (1) WO2001092534A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747293A (en) * 1995-03-23 1998-05-05 Imperial College Of Science, Technology & Medicine Intimin-like proteins of E. coli
US5698401A (en) * 1995-11-14 1997-12-16 Abbott Laboratories Use of nuclear magnetic resonance to identify ligands to target biomolecules
US5891643A (en) * 1995-11-14 1999-04-06 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
CA2309559A1 (en) * 1997-11-12 1999-05-20 B. Brett Finlay Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
GB9901897D0 (en) * 1999-01-29 1999-03-17 Imp College Innovations Ltd Biological material and use thereof

Also Published As

Publication number Publication date
WO2001092534A1 (en) 2001-12-06
GB0013115D0 (en) 2000-07-19
GB0112905D0 (en) 2001-07-18
GB2367294A (en) 2002-04-03

Similar Documents

Publication Publication Date Title
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
AU2001261080A1 (en) Methods and devices for draining fluids in and out of the body
AU2002223599A1 (en) Pyrimidinone derivatives and their use in the treatment of atherosclerosis
AU2001255655A1 (en) Treatment analysis systems and methods
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU2002219002A1 (en) Method and device for treating the surfaces of items
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
AU2001270484A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
AU2837301A (en) Use of polymeric material in the treatment of hard surfaces
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
AU2002364171A1 (en) Materials and methods for the treatment or prevention of obesity
AU2001265186A1 (en) Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
AU2002247973A1 (en) Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases
AU2001261375A1 (en) Human caspase-12 materials and methods
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
AU5565401A (en) Materials and methods for the treatment of depression
AU2001260457A1 (en) Biological materials and methods for use in the prevention or treatment of infections
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii